Cancer Risk in Patients With Fuchs Endothelial Corneal Dystrophy.

ABSTRACT:

Purpose

The purpose of this study is to quantify cancer risk in patients with Fuchs endothelial corneal dystrophy (FECD).

Methods

Using the 2014 to 2016 Medicare Limited 5% Data Sets-Carrier Line File, US Medicare fee-for-service beneficiaries (aged 65 years or older) with FECD and cancer were identified through International Classification of Diseases , ninth and 10th Revision diagnostic codes from January 1, 2014, to December 31, 2016. The main outcome measures were odds ratios (ORs) of cancer at various anatomic locations in patients with versus without FECD.

Results

Of the 1,462,740 Medicare beneficiaries, 15,534 patients (1.1%) had an International Classification of Disease code for FECD. Compared with US Medicare beneficiaries without FECD, patients with FECD we

SUBMITTER: Xu TT 

PROVIDER: S-EPMC9120714 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature